VEDA
LIVE

Serial Number

98091038

Owner

RH Studio 2 OpCo 53, Inc

Attorney

Elizabeth Oliner

Filing Date

Jul 18, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VEDA Trademark

Serial Number: 98091038

VEDA is a trademark filed by RH Studio 2 OpCo 53, Inc on July 18, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

RH Studio 2 OpCo 53, Inc (3 trademarks)

8th Floor 85 Fifth Avenue
New York, NY 10003

Entity Type: 03

VEDA LIFE SCIENCES, INC.

867 BOYLSTON ST., 5TH FLOOR #2054
BOSTON, MA 02116

Entity Type: 03

Trademark Details

Filing Date

July 18, 2023

Registration Date

Not Registered

Published for Opposition

March 24, 2026

Goods & Services

Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Platform as a service (PAAS) featuring computer software platforms for use in running, managing and analyzing clinical trials, namely, enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for use in managing and participating in clinical research and view data analytics, enabling site data capture, selecting configurable data collection methods with configurable options and configuring a participant-facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring non-downloadable software for use in clinical research analytics, data capture forms, electronic clinical outcome assessments (eCOA), recruitment, and electronic consent; Providing a website featuring non-downloadable software for enabling users to manage and participate in clinical research, view data analytics, enable site data capture, and screen participants for eligibility; Providing information in the field of clinical research via a website; Providing scientific research information in the field of clinical trials; none of the foregoing comprised of or consisting of the provision of healthcare or telehealth services, scheduling healthcare or telehealth appointments, or allowing a patient to access personal healthcare information for the provision of healthcare or telehealth services

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 19, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2026 CNSA
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Feb 25, 2026 LOPR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 30, 2025 ASGN
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 8, 2025 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 8, 2025 PARI
LETTER OF PROTEST EVIDENCE FORWARDED
Oct 21, 2024 LOPT
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Jun 29, 2024 LOPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 28, 2024 TROA
LETTER OF PROTEST EVIDENCE FORWARDED
Jun 7, 2024 LOPT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 24, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 24, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 24, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2023 NWOS
NEW APPLICATION ENTERED
Jul 21, 2023 NWAP